Scholars Central

Short communicationPublished 2013

Current Status of Fucanomics and Galactanomics in Drug Discovery and Glycomics

Authors: Vitor H Pomin

Journal of Glycobiology

Volume 2 · Issue 1 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Although many biomedical applications for sulfated fucans and galactans have been discovered over the past two decades, only in inflammation, hemostasis, and vascular biology and their mechanisms of actions have been satisfactorily elucidated to a real contribution in drug development. Moreover, advanced structure-function relationships have been achieved only for the anticoagulant and antithrombotic activities, in which glycans of welldefined structures have been assayed. Here, the current status, and the remaining challenges of fucanomics and galactanomics in drug discovery and in glycomics are presented.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Glycobiology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Glycobiology
  • SubjectBiochemistry & Biotechnology
  • SubjectPharmaceutical Sciences
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Vitor H Pomin”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels